As many studies have focused on the pharmacological interventions targeting PVAT eNOS in obesity, different targets that regulate eNOS in PVAT have been detailled [28,126,127]. The gene discussed is NOS3; the disease is obesity due to melanocortin 4 receptor deficiency.